VINRAB 1000 IU

Key Features

Anti-Rabies Immunoglobulin (RIG) – Key Features

1. Concentration & Strength
   • Contains 200 IU in 5 ml (40 IU/ml).
   • Human or equine-derived immunoglobulin.
2. Passive Immunity
   • Provides immediate, short-term protection by neutralizing the rabies virus at the site of entry.
3. Essential Part of Post-Exposure Prophylaxis (PEP)
   • Administered in conjunction with rabies vaccine for Category III exposures (as per WHO).
4. Wound Infiltration Priority
   • Infiltrated directly into and around the wound for maximum local virus neutralization.
5. Remaining Dose Given Intramuscularly
   • If excess volume remains after wound infiltration, it’s administered IM at a site distant from vaccine.
6. Used Only Once per Exposure
   • Not repeated; single-use per rabies exposure incident.
7. Available as Human or Equine RIG
   • HRIG (Human): Lower risk of allergic reaction, longer half-life.
   • ERIG (Equine): More affordable, requires test dose due to higher risk of hypersensitivity.
8. Sterile & Pyrogen-Free